Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass

Active, not recruitingOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2024

Conditions

Ovarian Cancer

Trial Locations (1)

Southern Illinois University School of Medicine, Springfield

All Listed Sponsors

collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Southern Illinois University

OTHER

NCT02109367 - Diagnostic Utility of Culdocentesis in Patients With a Suspicious Adnexal Mass | Biotech Hunter | Biotech Hunter